Optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal ranibizumab

Autor: Giuseppe de Crecchio, Nunzio Velotti, Francesca Amoroso, Gilda Cennamo, Mariacristina Alfieri, Stefano Schiemer
Přispěvatelé: Cennamo, Gilda, Amoroso, Francesca, Schiemer, Stefano, Velotti, Nunzio, Alfieri, Mariacristina, de Crecchio, Giuseppe
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
0301 basic medicine
medicine.medical_specialty
genetic structures
Fundus Oculi
Visual Acuity
Angiogenesis Inhibitors
choroidal neovascularization
03 medical and health sciences
0302 clinical medicine
Vessel density
Myopic choroidal neovascularization
Ophthalmology
vessel density
Pathologic myopia
Humans
Medicine
Prospective Studies
myopia
Fluorescein Angiography
ranibizumab
Aged
Retrospective Studies
business.industry
General Medicine
Optical coherence tomography angiography
Middle Aged
eye diseases
Vitreous Body
Treatment Outcome
030104 developmental biology
Choroidal neovascularization
Intravitreal Injections
Myopia
Degenerative

030221 ophthalmology & optometry
Female
sense organs
Ranibizumab
Intravitreal ranibizumab
medicine.symptom
business
Tomography
Optical Coherence

Follow-Up Studies
medicine.drug
Popis: Purpose: To describe the optical coherence tomography angiography characteristics of myopic patients with choroidal neovascularization secondary to pathologic myopia during ranibizumab therapy. Methods: Nineteen patients were enrolled in this prospective study (13 females, 6 males, mean age 55.25 ± 9.63 years) for a total of 20 eyes examined (14 right eyes, 6 left eyes). Images were analyzed independently by two examiners. Results: Mean follow-up was 5.75 ± 1.88 months, with a mean intravitreal injections of 1.90 ± 0.44. Mean best-corrected visual acuity at baseline was 0.39 ± 0.18 logMAR versus 0.26 ± 0.16 logMAR 6 months after treatment. The neovascular area (Z = –2.091, p = 0.037) was significantly reduced after treatment, whereas vessel density was not (Z = –1.848, p = 0.065). Moreover, the best-corrected visual acuity was increased (Z = –3.055, p = 0.002). Neovascular area was significantly correlated with best-corrected visual acuity, at both baseline and follow-up (p Conclusion: Our data suggest that optical coherence tomography angiography is a reproducible non-invasive examination with which to monitor changes in the neovascular area in patients with pathologic myopia treated with ranibizumab.
Databáze: OpenAIRE